Talon Therapeutics' Recently Approved Marqibo Presented at 2012 …

Published November 16, 2012

Talon Therapeutics' Recently Approved Marqibo Presented at 2012 …

Filed under: drug treatment news 2012

Marqibo received accelerated approval from the U.S. Food and Drug Administration on Aug. 9, 2012 for the treatment of adult patients with Ph- ALL in second or greater relapse or whose disease has progressed following two or more anti-leukemia therapies.
Read more on NASDAQ

Bayer: 5 key drugs to have combined peak sales of 5.5 billion euro

Filed under: drug treatment news 2012

LEVERKUSEN, Germany | Wed Nov 14, 2012 4:47am EST … The sales forecast comprises anti-clotting pill Xarelto, ophthalmic drug Eylea, also calle VEGF Trap-Eye, anti-cancer products Alpharadin and Stivarga, as well as lung treatment riociguat. Last year …
Read more on Reuters